London Stock Exchange · Healthcare
Invest in CelLBxHealth stock from India
Indian and foreign residents can buy CelLBxHealth (CLBX) shares directly through Paasa.
By Paasa · Updated
CelLBxHealth at a glance
- Price
- £0.01-£0.00 (2.86%)
- Market cap
- £9.66M
- Day range
- £0.01 – £0.01
- P/E
- —
- Dividend yield
- None
- Volume
- 5.68M
- 1 month
- -32.00%
- 6 months
- -8.11%
- YTD
- -22.73%
- 1 year
- -69.09%
- 5 years
- -99.37%
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Lonza | LONN.SW | CHF 575.20 | CHF 40.17B |
| GRAIL | GRAL | $140.12 | $6.01B |
| EnSilica | ENSI.L | £0.72 | £96.65M |
| Shield Therapeutics | STX.L | £0.06 | £64.39M |
| hVIVO | HVO.L | £0.06 | £41.65M |
| MDxHealth | MDXH | $0.58 | $30.03M |
| RUA Life Sciences | RUA.L | £0.29 | £18.00M |
| Oxford BioDynamics | OBD.L | £0.00 | £2.58M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in CelLBxHealth from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to GBP when you buy.
Step 3
Search CLBX and buy
Find CelLBxHealth by name or by its ticker, CLBX, and place your order.
Why invest in CelLBxHealth from India
What CelLBxHealth does
CelLBxHealth plc is a medical diagnostics firm specializing in the creation of cancer detection solutions, with operations spanning the United Kingdom, broader Europe, North America, and other global markets. A flagship offering is the Parsortix PC1 system, a medical device engineered to isolate and collect whole circulating tumor cells (CTCs) from the blood of patients with metastatic breast cancer, preparing them for further user-validated analysis. CelLBxHealth operates in the Medical - Diagnostics & Research industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Here's what inheritance rules in the UK mean for your CelLBxHealth shares.
Shares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents.
Frequently asked questions
Can I buy CelLBxHealth stock from India?
Yes. Indian residents and NRIs can buy CelLBxHealth (CLBX) shares directly through Paasa. CelLBxHealth is listed on the London Stock Exchange, in the Medical - Diagnostics & Research industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
How are CelLBxHealth dividends taxed for Indian investors?
CelLBxHealth does not currently pay a dividend, so there is nothing to withhold or declare today. If it starts paying one, the UK levies 0% withholding tax on company dividends paid to non-residents, and dividends are taxed at your slab rate in India.
What tax do I pay in India when I sell CelLBxHealth shares?
Non-residents are exempt from UK capital gains tax on the disposal of listed shares. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the GBP/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.
What happens to my CelLBxHealth shares if I pass away?
Shares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents. The rule looks at everything you hold there, not at CelLBxHealth alone.
Is there stamp duty when I buy CelLBxHealth shares?
The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it.